Siderophore receptor-mediated uptake of lactivicin analogues in gram-negative bacteria

Journal of Medicinal Chemistry

Volumn 57, Issue 9, 2014, Pages 3845-3855

  Starr, Jeremy ^a   Brown, Matthew F ^a   Aschenbrenner, Lisa ^a   Caspers, Nicole ^a   Che, Ye ^a   Gerstenberger, Brian S ^a   Huband, Michael ^a   Knafels, John D ^a   Lemmon, M Megan ^a   Li, Chao ^a   McCurdy, Sandra P ^a   McElroy, Eric ^a   Rauckhorst, Mark R ^a   Tomaras, Andrew P ^a   Young, Jennifer A ^a   Zaniewski, Richard P ^a   Shanmugasundaram, Veerabahu ^a   Han, Seungil ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; AZTREONAM; BETA LACTAMASE; CEFEPIME; CEPHALOSPORIN; DRUG RECEPTOR; LACTIVICIN; MONOBACTAM DERIVATIVE; PENICILLIN BINDING PROTEIN; SIDEROPHORE RECEPTOR; UNCLASSIFIED DRUG;

ACINETOBACTER BAUMANNII; ANTIBIOTIC SENSITIVITY; ARTICLE; CONTROLLED STUDY; CRYSTAL STRUCTURE; DRUG TARGETING; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; IC 50; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR INTERACTION; NONHUMAN; PSEUDOMONAS AERUGINOSA;

BETA-LACTAMASES; GRAM-NEGATIVE BACTERIA; MICROBIAL SENSITIVITY TESTS; PEPTIDES; RECEPTORS, CELL SURFACE; SIDEROPHORES;

EID: 84900335969     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm500219c     Document Type: Article

References (54)

1. Fleming, A. The antibacterial action of cultures of a Penicillium, with special reference to their use in the isolation of B. influenzae Br. J. Exp. Pathol. 1929, 10, 226-236
2. Boucher, H. W.; Talbot, G. H.; Bradley, J. S.; Edwards, J. E.; Gilbert, D.; Rice, L. B.; Scheld, M.; Spellberg, B.; Bartlett, J. Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America Clin. Infect. Dis. 2009, 48, 1-12
3. Solomkin, J. S.; Mazuski, J. E.; Bradley, J. S.; Rodvold, K. A.; Goldstein, E. J. C.; Baron, E. J.; ONeill, P. J.; Chow, A. W.; Dellinger, E. P.; Eachempati, S. R.; Gorbach, S.; Hilfiker, M.; May, A. K.; Nathens, A. B.; Sawyer, R. G.; Bartlett, J. G. Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America Clin. Infect. Dis. 2009, 50, 133-164
4. Anonymous. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am. J. Respir. Crit. Care Med. 2005, 171, 388-416.
5. Dellinger, R. P.; Levy, M. M.; Rhodes, A.; Annane, D.; Gerlach, H.; Opal, S. M.; Sevransky, J. E.; Sprung, C. L.; Douglas, I. S.; Jaeschke, R.; Osborn, T. M.; Nunnally, M. E.; Townsend, S. R.; Reinhart, K.; Kleinpell, R. M.; Angus, D. C.; Deutschman, C. S.; Machado, F. R.; Rubenfeld, G. D.; Webb, S. A.; Beale, R. J.; Vincent, J. L.; Moreno, R. Surviving sepsis campaign: International guidelines for management of severe sepsis and septic shock: 2012 Crit. Care Med. 2013, 41, 580-637
6. Livermore, D. M. Current epidemiology and growing resistance of Gram-negative pathogens Korean J. Intern. Med. 2012, 27, 128-142
7. Patel, G.; Bonomo, R. A. Status report on carbapenemases: challenges and prospects Expert Rev. Anti-Infect. Ther. 2011, 9, 555-570
8. Obrecht, D.; Bernardini, F.; Dale, G.; Dembowsky, K. Emerging new therapeutics against key Gram-negative pathogens Annu. Rep. Med. Chem. 2011, 46, 245-262
9. Waxman, D. J.; Strominger, J. L. Penicillin-binding proteins and the mechanism of action of β-lactam antibiotics Annu. Rev. Biochem. 1983, 52, 825-869
10. OShea, R.; Moser, H. E. Physicochemical properties of antibacterial compounds: implications for drug discovery J. Med. Chem. 2008, 51, 2871-2878
11. Wencewicz, T. A.; Moellmann, U.; Long, T. E.; Miller, M. J. Is drug release necessary for antimicrobial activity of siderophore-drug conjugates? Syntheses and biological studies of the naturally occurring salmycin "Trojan Horse" antibiotics and synthetic desferridanoxamine-antibiotic conjugates BioMetals 2009, 22, 633-648
12. Ji, C.; Juarez-Hernandez, R. E.; Miller, M. J. Exploiting bacterial iron acquisition: siderophore conjugates Future Med. Chem. 2012, 4, 297-313
13. Sykes, R. B.; Koster, W. H.; Bonner, D. P. The new monobactams: Chemistry and biology J. Clin. Pharmacol. 1988, 28, 113-119
14. Barbachyn, M. R.; Tuominen, T. C. Synthesis and structure-activity relationships of monocarbams leading to U-78608 J. Antibiot. 1990, 43, 1199-1203
15. Arnould, J. C.; Boutron, P.; Pasquet, M. J. Synthesis and antibacterial activity of C-4 substituted monobactams Eur. J. Med. Chem. 1992, 27, 131-140
16. Page, M. G. P.; Dantier, C.; Desarbre, E. In vitro properties of BAL30072, a novel siderophore sulfactam with activity against multiresistant Gram-negative bacilli Antimicrob. Agents Chemother. 2010, 54, 2291-2302
17. Mushtaq, S.; Warner, M.; Livermore, D. Activity of the siderophore monobactam BAL30072 against multiresistant non-fermenters J. Antimicrob. Chemother. 2010, 65, 266-270
18. Flanagan, M. E.; Brickner, S. J.; Lall, M.; Casavant, J.; Deschenes, L.; Finegan, S. M.; George, D. M.; Granskog, K.; Hardink, J. R.; Huband, M. D.; Hoang, T.; Lamb, L.; Marra, A.; Mitton-Fry, M.; Mueller, J. P.; Mullins, L. M.; Noe, M. C.; ODonnell, J. P.; Pattavina, D.; Penzien, J. B.; Schuff, B. P.; Sun, J.; Whipple, D. A.; Young, J.; Gootz, T. D. Preparation, Gram-negative antibacterial activity, and hydrolytic stability of novel siderophore-conjugated monocarbam diols ACS Med. Chem. Lett. 2011, 2, 385-390
19. Mitton-Fry, M. J.; Arcari, J. T.; Brown, M. F.; Casavant, J. M.; Finegan, S. M.; Flanagan, M. E.; Gao, H.; George, D. M.; Gerstenberger, B. S.; Han, S.; Hardink, J. R.; Harris, T. M.; Hoang, T.; Huband, M. D.; Irvine, R.; Lall, M. S.; Megan Lemmon, M.; Li, C.; Lin, J.; McCurdy, S. P.; Mueller, J. P.; Mullins, L.; Niosi, M.; Noe, M. C.; Pattavina, D.; Penzien, J.; Plummer, M. S.; Risley, H.; Schuff, B. P.; Shanmugasundaram, V.; Starr, J. T.; Sun, J.; Winton, J.; Young, J. A. Novel monobactams utilizing a siderophore uptake mechanism for the treatment of gram-negative infections Bioorg. Med. Chem. Lett. 2012, 22, 5989-5994
20. Brown, M. F.; Mitton-Fry, M. J.; Arcari, J. T.; Barham, R.; Casavant, J.; Gerstenberger, B. S.; Han, S.; Hardink, J. R.; Harris, T. M.; Hoang, T.; Huband, M. D.; Lall, M. S.; Lemmon, M. M.; Li, C.; Lin, J.; McCurdy, S. P.; McElroy, E.; McPherson, C.; Marr, E. S.; Mueller, J. P.; Mullins, L.; Nikitenko, A. A.; Noe, M. C.; Penzien, J.; Plummer, M. S.; Schuff, B. P.; Shanmugasundaram, V.; Starr, J. T.; Sun, J.; Tomaras, A.; Young, J. A.; Zaniewski, R. P. Pyridone-conjugated monobactam antibiotics with Gram-negative activity J. Med. Chem. 2013, 56, 5541-5552
21. Harada, S.; Tsubotani, S.; Hida, T.; Ono, H.; Okazaki, H. Structure of lactivicin, an antibiotic having a new nucleus and similar biological activities to β-lactam antibiotics Tetrahedron Lett. 1986, 27, 6229-6232
22. Nozaki, Y.; Katayama, N.; Ono, H.; Tsubotani, S.; Harada, S.; Okazaki, H.; Nakao, Y. Binding of a non-beta-lactam antibiotic to penicillin-binding proteins Nature 1987, 325, 179-180
23. Nozaki, Y.; Katayama, N.; Harada, S.; Ono, H.; Okazaki, H. Lactivicin, a naturally occurring non-β-lactam antibiotic having β-lactam-like action: biological activities and mode of action J. Antibiot. 1989, 42, 84-93
24. Aszodi, J.; Rowlands, D. A.; Mauvais, P.; Collette, P.; Bonnefoy, A.; Lampilas, M. Design and synthesis of bridged ?-lactams as analogues of β-lactam antibiotics Bioorg. Med. Chem. Lett. 2004, 14, 2489-2492
25. Coleman, K. Diazabicyclooctanes (DBOs): A potent new class of non-β-lactam β-lactamase inhibitors Curr. Opin. Microbiol. 2011, 14, 550-555
26. Zervosen, A.; Sauvage, E.; Frere, J.-M.; Charlier, P.; Luxen, A. Development of new drugs for an old target-the penicillin binding proteins Molecules 2012, 17, 12478-12505
27. Macheboeuf, P.; Fischer, D. S.; Brown, T., Jr.; Zervosen, A.; Luxen, A.; Joris, B.; Dessen, A.; Schofield, C. J. Structural and mechanistic basis of penicillin-binding protein inhibition by lactivicins Nat. Chem. Biol. 2007, 3, 565-569
28. Boyd, D. B.; Herron, D. K.; Lunn, W. H. W.; Spitzer, W. A. Electronic structures of cephalosporins and penicillins. 11. Parabolic relationships between antibacterial activity of cephalosporins and β-lactam reactivity predicted from molecular orbital calculations J. Am. Chem. Soc. 1980, 102, 1812-1814
29. Harada, S.; Tsubotani, S.; Hida, T.; Koyama, K.; Kondo, M.; Ono, H. Chemistry of a new antibiotic: Lactivicin Tetrahedron 1988, 44, 6589-6606
30. Wolfe, S.; Wilson, M.-C.; Cheng, M.-H.; Shustov, G. V.; Akuche, C. I. Cyclic hydroxamates, especially multiply substituted [1,2]oxazinan-3-ones Can. J. Chem. 2003, 81, 937-960
31. Baldwin, J. E.; Ng, S. C.; Pratt, A. J. Synthesis of phenoxyacetyl-N- sulphonyl cycloserine Tetrahedron Lett. 1987, 28, 4319-4320
32. Ueda, Y.; Crast, L. B., Jr.; Mikkilineni, A. B.; Partyka, R. A. Synthesis of phenoxyacetyl-N-(hydroxydioxocyclobutenyl)cycloserines Tetrahedron Lett. 1991, 32, 3767-3770
33. Natsugari, H.; Kawano, Y.; Morimoto, A.; Yoshioka, K.; Ochiai, M. Synthesis of lactivicin and its derivatives J. Chem. Soc., Chem. Commun. 1987, 62-63
34. Tamura, N.; Matsushita, Y.; Yoshioka, K.; Ochiai, M. Synthesis of lactivicin analogs Tetrahedron 1988, 44, 3231-3240
35. Tamura, N.; Matsushita, Y.; Kawano, Y.; Yoshioka, K. Synthesis and antibacterial activity of lactivicin derivatives Chem. Pharm. Bull. 1990, 38, 116-122
36. Han, S.; Zaniewski, R. P.; Marr, E. S.; Lacey, B. M.; Tomaras, A. P.; Evdokimov, A.; Miller, J. R.; Shanmugasundaram, V. Structural basis for effectiveness of siderophore-conjugated monocarbams against clinically relevant strains of Pseudomonas aeruginosa Proc. Natl. Acad. Sci. U. S.A. 2010, 107, 22002-22007
37. Baudart, M. G.; Hennequin, L. F. Synthesis and biological activity of C-3′ ortho-dihydroxyphthalimido cephalosporins J. Antibiot. 1993, 46, 1458-1470
38. Han, S.; Caspers, N.; Zaniewski, R. P.; Lacey, B. M.; Tomaras, A. P.; Feng, X.; Geoghegan, K. F.; Shanmugasundaram, V. Distinctive attributes of β-lactam target proteins in Acinetobacter baumannii relevant to development of new antibiotics J. Am. Chem. Soc. 2011, 133, 20536-20545
39. Winsor, G. L.; Lam, D. K. W.; Fleming, L.; Lo, R.; Whiteside, M. D.; Yu, N. Y.; Hancock, R. E. W.; Brinkman, F. S. L. Pseudomonas genome database: Improved comparative analysis and population genomics capability for Pseudomonas genomes Nucleic Acids Res. 2011, 39, D596-D600
40. McPherson, C. J.; Aschenbrenner, L. M.; Lacey, B. M.; Fahnoe, K. C.; Lemmon, M. M.; Finegan, S. M.; Tadakamalla, B.; ODonnell, J. P.; Mueller, J. P.; Tomaras, A. P. Clinically relevant Gram-negative resistance mechanisms have no effect on the efficacy of MC-1, a novel siderophore-conjugated monocarbam Antimicrob. Agents Chemother. 2012, 56, 6334-6342
41. Carpenter, B. M.; Whitmire, J. M.; Merrell, D. S. This is not your mothers repressor: The complex role of Fur in pathogenesis Infect. Immun. 2009, 77, 2590-2601
42. Tomaras, A. P.; Crandon, J. L.; McPherson, C. J.; Banevicius, M. A.; Finegan, S. M.; Irvine, R. L.; Brown, M. F.; ODonnell, J. P.; Nicolau, D. P. Adaptation-based resistance to siderophore-conjugated antibacterial agents by Pseudomonas aeruginosa Antimicrob. Agents Chemother. 2013, 57, 4197-4207
43. Brown, T., Jr.; Charlier, P.; Herman, R.; Schofield, C. J.; Sauvage, E. Structural basis for the interaction of lactivicins with serine β-lactamases J. Med. Chem. 2010, 53, 5890-5894
44. Rodkey, E. A.; Drawz, S. M.; Sampson, J. M.; Bethel, C. R.; Bonomo, R. A.; van den Akker, F. Crystal structure of a preacylation complex of the β-lactamase inhibitor sulbactam bound to a sulfenamide bond-containing thiol-β-lactamase J. Am. Chem. Soc. 2012, 134, 16798-16804
45. Otwinowski, Z.; Minor, W. Processing of X-ray diffraction data collected in oscillation mode Methods Enzymol. 1997, 276, 307-326
46. McCoy, A. J.; Grosse-Kunstleve, R. W.; Adams, P. D.; Winn, M. D.; Storoni, L. C.; Read, R. J. Phaser crystallographic software J. Appl. Crystallogr. 2007, 40, 658-674
47. Blanc, E.; Roversi, P.; Vonrhein, C.; Flensburg, C.; Lea, S. M.; Bricogne, G. Refinement of severely incomplete structures with maximum likelihood in BUSTER-TNT Acta Crystallogr., Sect. D: Biol. Crystallogr. 2004, 60, 2210-2221
48. Emsley, P.; Cowtan, K. Coot: model-building tools for molecular graphics Acta Crystallogr., Sect. D.: Biol. Crystallogr. 2004, 60, 2126-2132
49. Laskowski, R. A.; Moss, D. S.; Thornton, J. M. Main-chain bond lengths and bond angles in protein structures J. Mol. Biol. 1993, 231, 1049-1067
50. Frisch, M. J.; Schlegel, H. B.; Scuseria, G. E.; Robb, M. A.; Cheeseman, J. R.;; Scalmani, G.; Barone, V.; Mennucci, B.; Petersson, G. A.; Nakatsuji, H.; Caricato, M.; Li, X.; Hratchian, H. P.; Izmaylov, A. F.; Bloino, J.; Zheng, G.; Sonnenberg, J. L.; Hada, M.; Ehara, M.; Toyota, K.; Fukuda, R.; Hasegawa, J.; Ishida, M.; Nakajima, T.; Honda, Y.; Kitao, O.; Nakai, H.; Vreven, T.; J. A. Montgomery, J.; Peralta, J. E.; Ogliaro, F.; Bearpark, M.; Heyd, J. J.; Brothers, E.; Kudin, K. N.; Staroverov, V. N.; Kobayashi, R.; Normand, J.; Raghavachari, K.; Rendell, A.; Burant, J. C.; Iyengar, S. S.; Tomasi, J.; Cossi, M.; Rega, N.; Millam, J. M.; Klene, M.; Knox, J. E.; Cross, J. B.; Bakken, V.; Adamo, C.; Jaramillo, J.; Gomperts, R.; Stratmann, R. E.; Yazyev, O.; Austin, A. J.; Cammi, R.; Pomelli, C.; Ochterski, J. W.; Martin, R. L.; Morokuma, K.; Zakrzewski, V. G.; Voth, G. A.; Salvador, P.; Dannenberg, J. J.; Dapprich, S.; Daniels, A. D.; Farkas, Ö.; Foresman, J. B.; Ortiz, J. V.; Cioslowski, J.; Fox, D. J. Gaussian 09, Revision C.1; Gaussian, Inc., Wallingford, CT, 2009.
51. Andersson, M. P.; Uvdal, P. New scale factors for harmonic vibrational frequencies using the B3LYP density functional method with the triple-Ζ basis set 6-311+G(d,p) J. Phys. Chem. A 2005, 109, 2937-2941
52. Marenich, A. V.; Cramer, C. J.; Truhlar, D. G. Universal solvation model based on solute electron density and on a continuum model of the Solvent defined by the bulk dielectric constant and atomic surface tensions J. Phys. Chem. B 2009, 113, 6378-6396
53. Gonzalez, C.; Schlegel, H. B. Reaction path following in mass-weighted internal coordinates J. Phys. Chem. 1990, 94, 5523-5527
54. Clinical Laboratory Standards Institute (CLSI). Methodsfor dilution antimicrobial susceptibility tests for bacteria thatgrow aerobically: approved standard. CLSI, M07, (2009a. CLSI. Performance standards for antimicrobial susceptibility testing: 19th informational supplement. CLSI, M100, 2009b.